Indometacin

Indometacin, the active ingredient in Indometacin, is a Nonsteroidal anti-inflammatory drug (NSAID) presented as a tablet for oral use. It reduces inflammation and pain in conditions such as rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, gout and acute pain. It is indicated for the management of inflammatory musculoskeletal disorders and acute gout attacks, offering clinicians an option to control pain and swelling.

GNH USA supplies Indometacin as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies, and clinics worldwide with adherence to stringent quality standards and regulatory requirements.

Indometacin is an NSAID that reduces inflammation and pain in several musculoskeletal and crystal‑induced arthropathies.

- Rheumatoid arthritis: alleviates joint inflammation and pain, improving functional ability. - Osteoarthritis: decreases cartilage‑related discomfort and swelling during movement. - Ankylosing spondylitis: reduces spinal inflammation and stiffness, aiding mobility. - Gout: relieves acute gouty arthritis attacks by lowering inflammatory response. - Acute pain: provides rapid analgesia for short‑term severe pain episodes.

Indometacin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, or abdominal pain. - Headache: mild to moderate intensity. - Dizziness: transient sensation of light‑headedness. - Skin rash: mild erythema or itching.

Serious or Rare Side Effects: - Peptic ulcer or gastrointestinal bleeding: potentially life‑threatening hemorrhage. - Hepatotoxicity: elevated liver enzymes or hepatitis. - Severe hypersensitivity: anaphylaxis, Stevens‑Johnson syndrome, or toxic epidermal necrolysis.

Before prescribing Indometacin, clinicians should consider several precautionary measures to minimize risk. - Assess renal function: monitor creatinine and adjust use in renal impairment. - Evaluate gastrointestinal risk: avoid in patients with active ulcers or history of bleeding. - Check cardiovascular status: use cautiously in those with heart disease or hypertension. - Review concomitant medications: avoid combining with other NSAIDs or anticoagulants without supervision. - Monitor liver enzymes: periodic testing recommended during prolonged therapy. - Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture.

Indometacin can interact with other medicines, influencing efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - ACE inhibitors or ARBs: may reduce antihypertensive effect and impair renal function. - Lithium: heightened lithium levels leading to toxicity.

Moderate Interactions (Monitor Closely): - Diuretics: may exacerbate renal impairment and electrolyte imbalance. - Methotrexate: reduced clearance increasing toxicity. - Corticosteroids: additive gastrointestinal ulcer risk.